Fri, March 8, 2013
Thu, March 7, 2013
Wed, March 6, 2013
Tue, March 5, 2013
Mon, March 4, 2013
Sun, March 3, 2013
Sat, March 2, 2013
Fri, March 1, 2013
Thu, February 28, 2013
Wed, February 27, 2013
Tue, February 26, 2013
Mon, February 25, 2013
Sun, February 24, 2013
Sat, February 23, 2013
Fri, February 22, 2013
Thu, February 21, 2013
Wed, February 20, 2013
Tue, February 19, 2013
Mon, February 18, 2013
Sun, February 17, 2013
Fri, February 15, 2013
Thu, February 14, 2013
Wed, February 13, 2013

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference


  Copy link into your clipboard //health-fitness.news-articles.net/content/2013/ .. d-company-33rd-annual-healthcare-conference.html
  Print publication without navigation Published in Health and Fitness on by Market Wire
          🞛 This publication is a summary or evaluation of another publication

February 26, 2013 09:00 ET

Dynavax to Present at the Cowen and Company 33rd Annual Healthcare Conference

BERKELEY, CA--(Marketwire - Feb 26, 2013) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it will present at the Cowen and Company 33rd Annual Healthcare Conference in Boston on Tuesday, March 5, 2013 at 8:40 a.m. Eastern Time (5:40 a.m. Pacific Time).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV , a Phase 3 investigational adult hepatitis B vaccine. For more information visit [ www.dynavax.com ].



Publication Contributing Sources